House of Lords Business
Show full summary

Lord Empey to ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 26 February (HL1925), (1) whether they will provide a breakdown of how the £360 million invested in antimicrobial resistance research since 2014 was spent, (2) what assessment they have made of the outcomes from the investment in antimicrobial resistance to date, and (3) what is their strategy for incentivising the pharmaceutical industry to develop antibiotics.  HL2493

Question HL2493: tabled on 11 March 2020 and due for answer by 25 March 2020

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Empey to ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 26 February (HL1925), (1) whether they will provide a breakdown of how the £360 million invested in antimicrobial resistance research since 2014 was spent, (2) what assessment they have made of the outcomes from the investment in antimicrobial resistance to date, and (3) what is their strategy for incentivising the pharmaceutical industry to develop antibiotics.  HL2493
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Empey
Ulster Unionist Party
Life peer